9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease
9000 URETHRA STUDY: a Prospective, Observational Study About Urethroplasty for Urethral Stricture Disease
University Hospital, Ghent
1,000 participants
Sep 1, 2019
OBSERVATIONAL
Conditions
Summary
It has been demonstrated that urethroplasty should be considered the gold standard treatment for urethral stricture disease as it yields higher long-term success rates than endoscopic treatment options such as direct vision internal urethrotomy (DVIU) or dilation. Many data about these procedures exist, although most of the publications about urethroplasty are retrospective and involve a tremendous risk of bias. To address these issues, this study is designed to prospectively gain evidence about this matter in all patient subgroups facing a potential treatment with urethroplasty: native men, native women, transmen, transwomen and children.
Eligibility
Inclusion Criteria3
- Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations.
- Patient age ≥ 6 years.
- If a patient reaches the age of 18 years, he or she will have to provide a new voluntarily signed written informed consent. All patients reaching the age of 18 years will be contacted by the Principal Investigator or Subinvestigator to provide a new voluntarily signed written informed consent.
Exclusion Criteria1
- \- Absence of signed written informed consent and thus a patient unwilling to participate.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Open reconstructive surgery to restore urethral patency in case of urethral stricture disease.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04071925